Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
| Actual shortage: | 217 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TELMISARTAN-AMLODIPINE | 10MG 80MG | TABLET | Actual shortage | 2022-03-16 | 2022-09-14 | 156794 |
| APO-TELMISARTAN-AMLODIPINE | 5MG 80MG | TABLET | Actual shortage | 2022-02-23 | 2022-09-14 | 155482 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Resolved | 2019-04-10 | 2019-04-12 | 80923 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Resolved | 2020-04-01 | 2020-06-02 | 110297 |
| ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Resolved | 2019-08-21 | 2019-10-07 | 92010 |
| ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Resolved | 2019-12-05 | 2020-01-07 | 100200 |
| ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Resolved | 2020-04-01 | 2020-04-13 | 110315 |
| ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Resolved | 2020-04-01 | 2020-04-01 | 110331 |
| ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Resolved | 2023-01-20 | 2023-02-23 | 181973 |
| ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Resolved | 2020-04-01 | 2020-05-25 | 110329 |
| ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Resolved | 2017-07-26 | 2017-10-05 | 17195 |
| ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Resolved | 2020-04-01 | 2020-05-25 | 110339 |
| ACID REDUCER | 75MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19042 |
| ALLERGY RELIEF | 10MG | TABLET | Resolved | 2020-07-08 | 2020-08-24 | 119673 |
| ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2024-10-24 | 2025-01-10 | 241066 |
| ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2018-02-27 | 2018-05-03 | 41160 |
| ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2019-11-20 | 2019-12-09 | 99287 |
| ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2024-09-12 | 2024-09-20 | 237351 |
| ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2019-05-15 | 2019-08-08 | 84096 |
| ALYSENA 28 | 20MCG 100MCG | TABLET | Resolved | 2020-03-18 | 2020-04-13 | 108920 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |